Total Payments
$3,686
2024 Payments
$2,328
Companies
28
Transactions
170
Medicare Patients
277
Medicare Billing
$63,046
Payment Breakdown by Category
Food & Beverage$3,632 (98.5%)
Education$53.90 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,632 | 167 | 98.5% |
| Education | $53.90 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $660.47 | 21 | $0 (2024) |
| Travere Therapeutics, Inc. | $454.81 | 36 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $299.36 | 10 | $0 (2024) |
| Amgen Inc. | $289.32 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $268.11 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $219.98 | 12 | $0 (2024) |
| Vifor Pharma, Inc. | $171.77 | 8 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $170.81 | 10 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $155.53 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $134.05 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,328 | 122 | Travere Therapeutics, Inc. ($415.82) |
| 2023 | $866.74 | 34 | Calliditas Therapeutics US Inc. ($195.31) |
| 2022 | $491.22 | 14 | Aurinia Pharma U.S., Inc. ($265.23) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Nephrology | ||||||
| 12/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: Nephrology | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEPHROLOGY | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Hyperkalemia | ||||||
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $30.13 | General |
| 11/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $1.42 | General |
| 11/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.64 | General |
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Nephrology | ||||||
| 10/30/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Nephrology | ||||||
| 10/25/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Nephrology | ||||||
| 10/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Nephrology | ||||||
| 09/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Nephrology | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Hyperkalemia | ||||||
| 09/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Rare Disease | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 277 | 578 | $160,805 | $63,046 |
Total Patients
277
Total Services
578
Medicare Billing
$63,046
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 108 | 380 | $104,500 | $37,882 | 36.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 67 | $21,105 | $9,735 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $18,000 | $8,519 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 56 | $15,400 | $6,014 | 39.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 15 | $1,800 | $895.50 | 49.8% |
About Jonathan Sung
Jonathan Sung is a Nephrology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2018. The National Provider Identifier (NPI) number assigned to this provider is 1477057859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Sung has received a total of $3,686 in payments from pharmaceutical and medical device companies, with $2,328 received in 2024. These payments were reported across 170 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,632).
As a Medicare-enrolled provider, Sung has provided services to 277 Medicare beneficiaries, totaling 578 services with total Medicare billing of $63,046. Data is available for 1 year (2023–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Torrance, CA
- Active Since 03/21/2018
- Last Updated 07/21/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1477057859
Products in Payments
- LUPKYNIS (Drug) $660.47
- TARPEYO (Drug) $299.36
- JYNARQUE (Drug) $268.11
- Kerendia (Drug) $219.98
- TAVNEOS (Drug) $168.79
- Veltassa (Drug) $149.18
- JARDIANCE (Drug) $134.05
- KRYSTEXXA (Biological) $120.53
- Velphoro (Drug) $109.85
- Ozempic (Drug) $106.44
- IBSRELA (Drug) $103.55
- LIVTENCITY (Drug) $101.60
- ACTHAR (Biological) $97.38
- Vafseo (Drug) $90.27
- Auryxia (Drug) $80.54
- RAYALDEE (Drug) $72.03
- TERLIVAZ (Drug) $58.15
- ULTOMIRIS (Biological) $48.78
- ENVARSUS (Drug) $33.88
- FARXIGA (Drug) $31.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Torrance
Sharon Adler, M.d, M.D
Nephrology — Payments: $59,443
Nephrology $59,443
Mr. Vinh Cam, M.d, M.D
Nephrology — Payments: $54,266
Nephrology $54,266
Anuja Shah, M.d, M.D
Nephrology — Payments: $30,003
Nephrology $30,003
Joel Kopple, M.d, M.D
Nephrology — Payments: $19,801
Nephrology $19,801
Dr. Philip Chung, M.d, M.D
Nephrology — Payments: $13,883
Nephrology $13,883
Mahdi Yazdany, M.d, M.D
Nephrology — Payments: $12,637
Nephrology $12,637